(MedPage Today) — The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered markers linked to Alzheimer’s disease in a pilot study involving two open-label trials.
In a year…
(MedPage Today) — The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered markers linked to Alzheimer’s disease in a pilot study involving two open-label trials.
In a year…